Login / Signup

Edoxaban for the treatment of pulmonary embolism in hospitalized COVID-19 patients.

Valerio LangellaRoberta BottinoAntonio AstiGiulio MarescaGisella Di PalmaDomenico PomponiClaudia SassoneEgidio ImbalzanoVincenzo Russo
Published in: Expert review of clinical pharmacology (2021)
Edoxaban was an effective and safe treatment for acute PE in COVID-19 setting.
Keyphrases
  • pulmonary embolism
  • sars cov
  • coronavirus disease
  • venous thromboembolism
  • liver failure
  • combination therapy
  • respiratory failure
  • aortic dissection